2 in 1: Multi-tasking protein provides new approaches for anti-tuberculosis drugs
Tuesday, February 15, 2011 - 13:00
in Biology & Nature
In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, the bacterium that causes tuberculosis. The new findings present possible new opportunities for developing organism-specific drugs, which target the pathogen but leave other microorganisms, which are beneficial to us, untouched.
